Dr. Asiago-Reddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Irving Ave
Ste 314
Syracuse, NY 13210Phone+1 315-464-9360Fax+1 315-464-9361
Summary
- Dr. Elizabeth Asiago-Reddy is an Infectious Disease specialist based in Syracuse, NY. She gained her degree in 2002 from the University of Rochester School of Medicine and Dentistry, and further specialized in Internal Medicine/Pediatrics through her residency at the Icahn School of Medicine at Mount Sinai (2002-2006). She later completed her fellowship in Infectious Disease at Duke University Hospital (2006-2010). Dr. Asiago-Reddy has made significant contributions to medical research, with multiple published papers in highly recognized journals such as Pharmacotherapy, International Journal of Antimicrobial Agents, AIDS and Behavior, and Vaccine, some of which were cited several times by other publications.
Education & Training
- Duke University HospitalFellowship, Infectious Disease, 2006 - 2010
- Icahn School of Medicine at Mount SinaiResidency, Internal Medicine/Pediatrics, 2002 - 2006
- University of Rochester School of Medicine and DentistryClass of 2002
Certifications & Licensure
- NY State Medical License 2004 - 2025
- NC State Medical License 2006 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Persistent methicillin-resistant Staphylococcus aureus (MRSA) nares test positivity during initial days of systemic antistaphylococcal antimicrobial therapy.Maximillian S Wu, Wesley Kufel, Scott Riddell, Jeff Steele, Elizabeth Asiago-Reddy
American Journal of Infection Control. 2025-01-01 - 3 citationsConsensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorse...David B Cluck, Daniel B Chastain, Milena Murray, Spencer H Durham, Elias B Chahine
Pharmacotherapy. 2024-05-01 - Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorse...David B Cluck, Daniel B Chastain, Milena Murray, Spencer H Durham, Elias B Chahine
Pharmacotherapy. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: